Tarter
Microsoft has discontinued support for Internet Explorer. To access the Tarter website, please install a modern browser like Microsoft Edge or Google Chrome.

On January 28, 2021, Janet Linn will moderate the CLE “Skinny Labels and Patent Infringement” for the NYSBA Food, Drug & Cosmetic Law Section Annual Meeting. During the CLE, the speakers will explore liability for induced patent infringement in light of the GSK v. Teva and Amarin v. Hikma & HealthNet decision. The panel will discuss avenues for insurers, PBMs, and pharmacies, as well as generic companies, to reduce the risk of being liable for infringement.

Learn more and register here.

Janet Linn to Moderate CLE on Skinny Labels and Patent Infringement for New York State Bar Association’s (NYSBA) Food, Drug & Cosmetic Law Section Annual Meeting

Janet Linn to Moderate CLE on Skinny Labels and Patent Infringement for New York State Bar Association’s (NYSBA) Food, Drug & Cosmetic Law Section Annual Meeting

Janet Linn to Moderate CLE on Skinny Labels and Patent Infringement for New York State Bar Association’s (NYSBA) Food, Drug & Cosmetic Law Section Annual Meeting
When: January 28, 2021
People: Janet B. Linn

On January 28, 2021, Janet Linn will moderate the CLE “Skinny Labels and Patent Infringement” for the NYSBA Food, Drug & Cosmetic Law Section Annual Meeting. During the CLE, the speakers will explore liability for induced patent infringement in light of the GSK v. Teva and Amarin v. Hikma & HealthNet decision. The panel will discuss avenues for insurers, PBMs, and pharmacies, as well as generic companies, to reduce the risk of being liable for infringement.

Learn more and register here.

Janet Linn to Moderate CLE on Skinny Labels and Patent Infringement for New York State Bar Association’s (NYSBA) Food, Drug & Cosmetic Law Section Annual Meeting

Janet Linn to Moderate CLE on Skinny Labels and Patent Infringement for New York State Bar Association’s (NYSBA) Food, Drug & Cosmetic Law Section Annual Meeting

Janet Linn to Moderate CLE on Skinny Labels and Patent Infringement for New York State Bar Association’s (NYSBA) Food, Drug & Cosmetic Law Section Annual Meeting

Janet Linn to Moderate CLE on Skinny Labels and Patent Infringement for New York State Bar Association’s (NYSBA) Food, Drug & Cosmetic Law Section Annual Meeting

Janet Linn to Moderate CLE on Skinny Labels and Patent Infringement for New York State Bar Association’s (NYSBA) Food, Drug & Cosmetic Law Section Annual Meeting
When: January 28, 2021
People: Janet B. Linn

On January 28, 2021, Janet Linn will moderate the CLE “Skinny Labels and Patent Infringement” for the NYSBA Food, Drug & Cosmetic Law Section Annual Meeting. During the CLE, the speakers will explore liability for induced patent infringement in light of the GSK v. Teva and Amarin v. Hikma & HealthNet decision. The panel will discuss avenues for insurers, PBMs, and pharmacies, as well as generic companies, to reduce the risk of being liable for infringement.

Learn more and register here.

Janet Linn to Moderate CLE on Skinny Labels and Patent Infringement for New York State Bar Association’s (NYSBA) Food, Drug & Cosmetic Law Section Annual Meeting
When: January 28, 2021
People: Janet B. Linn

On January 28, 2021, Janet Linn will moderate the CLE “Skinny Labels and Patent Infringement” for the NYSBA Food, Drug & Cosmetic Law Section Annual Meeting. During the CLE, the speakers will explore liability for induced patent infringement in light of the GSK v. Teva and Amarin v. Hikma & HealthNet decision. The panel will discuss avenues for insurers, PBMs, and pharmacies, as well as generic companies, to reduce the risk of being liable for infringement.

Learn more and register here.

Janet Linn to Moderate CLE on Skinny Labels and Patent Infringement for New York State Bar Association’s (NYSBA) Food, Drug & Cosmetic Law Section Annual Meeting

Janet Linn to Moderate CLE on Skinny Labels and Patent Infringement for New York State Bar Association’s (NYSBA) Food, Drug & Cosmetic Law Section Annual Meeting